Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$14.0 - $20.72 $10,136 - $15,001
-724 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$12.67 - $26.23 $4,586 - $9,495
362 Added 100.0%
724 $14,000
Q2 2020

Jul 20, 2020

BUY
$7.53 - $14.93 $2,725 - $5,404
362 New
362 $5,000
Q1 2019

Apr 15, 2019

SELL
$28.4 - $41.74 $10,280 - $15,109
-362 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$30.9 - $42.97 $11,185 - $15,555
362 New
362 $13,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.13B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Ropes Wealth Advisors LLC Portfolio

Follow Ropes Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.